| VRTX | Vertex Pharmaceuticals Inc | $121.26B | +1127436.63% |
| VRNA | Verona Pharma Plc | $77.75B | +722855.27% |
| REGN | Regeneron Pharmaceuticals Inc | $69.10B | +642471.02% |
| ARGX | Argen X SE | $57.12B | +531077.13% |
| ALNY | Alnylam Pharmaceuticals Inc | $36.95B | +343502.90% |
| RVMD | Revolution Medicines Inc | $36.92B | +343219.37% |
| ONC | BeiGene Ltd | $36.03B | +334981.03% |
| MRNA | Moderna Inc | $27.11B | +251963.24% |
| ROIV | Roivant Sciences Ltd | $25.13B | +233606.86% |
| RPRX | Royalty Pharma plc - Class A | $24.60B | +228609.24% |
| INSM | Insmed Inc | $23.78B | +220990.00% |
| BNTX | BioNTech SE | $23.26B | +216215.64% |
| INCY | Incyte Corp | $23.01B | +213883.86% |
| GMAB | Genmab | $18.57B | +172570.31% |
| ASND | Ascendis Pharma A/S | $17.33B | +161035.21% |
| BBIO | BridgeBio Pharma Inc | $16.18B | +150328.04% |
| JAZZ | Jazz Pharmaceuticals plc | $14.81B | +137651.12% |
| EXEL | Exelixis Inc | $14.09B | +130948.40% |
| MDGL | Madrigal Pharmaceuticals Inc | $12.68B | +117797.38% |
| AXSM | Axsome Therapeutics Inc | $12.21B | +113474.23% |
| SMMT | Summit Therapeutics Inc | $11.69B | +108645.24% |
| BMRN | Biomarin Pharmaceutical Inc | $11.39B | +105842.74% |
| TECH | Bio-Techne Corp | $11.19B | +103932.50% |
| ABVX | Abivax | $10.86B | +100867.30% |
| KRYS | Krystal Biotech Inc | $10.31B | +95770.45% |
| CYTK | Cytokinetics Inc | $10.18B | +94606.25% |
| ARWR | Arrowhead Pharmaceuticals Inc | $10.10B | +93778.61% |
| APGE | Apogee Therapeutics Inc | $10.06B | +93408.03% |
| NUVL | Nuvalent Inc - Class A | $9.75B | +90581.41% |
| KYMR | Kymera Therapeutics Inc | $9.38B | +87109.64% |
| CORT | Corcept Therapeutics Inc | $9.35B | +86882.95% |
| IONS | Ionis Pharmaceuticals Inc | $9.08B | +84331.15% |
| HALO | Halozyme Therapeutics Inc | $8.99B | +83462.59% |
| PRAX | Praxis Precision Medicines Inc | $8.87B | +82389.63% |
| CRNX | Crinetics Pharmaceuticals Inc | $8.84B | +82062.48% |
| PTGX | Protagonist Therapeutics Inc | $8.70B | +80801.13% |
| TGTX | TG Therapeutics Inc | $8.64B | +80204.41% |
| PCVX | Vaxcyte Inc | $8.19B | +76042.34% |
| IMVT | Immunovant Inc | $8.13B | +75528.21% |
| IBRX | ImmunityBio Inc | $8.10B | +75182.35% |
| SYRE | Spyre Therapeutics Inc | $8.05B | +74728.91% |
| RYTM | Rhythm Pharmaceuticals Inc | $7.51B | +69712.76% |
| MTSR | Metsera Inc | $7.40B | +68754.09% |
| MIRM | Mirum Pharmaceuticals Inc | $7.37B | +68451.14% |
| MRUS | Merus N.V | $6.83B | +63370.47% |
| COGT | Cogent Biosciences Inc | $6.71B | +62307.86% |
| ACLX | Arcellx Inc | $6.67B | +61884.92% |
| XENE | Xenon Pharmaceuticals Inc | $6.54B | +60736.45% |
| PTCT | PTC Therapeutics Inc | $6.53B | +60662.06% |
| CDTX | Cidara Therapeutics Inc | $6.49B | +60288.72% |
| SRRK | Scholar Rock Holding Corp | $6.44B | +59750.30% |
| CGON | Cg Oncology Inc | $6.42B | +59640.56% |
| CNTA | Centessa Pharmaceuticals plc | $6.27B | +58170.96% |
| TERN | Terns Pharmaceuticals Inc | $5.95B | +55205.29% |
| LGND | Ligand Pharmaceuticals Inc - Class B | $5.93B | +55076.96% |
| BLTE | Belite Bio Inc | $5.88B | +54578.10% |
| ERAS | Erasca Inc | $5.51B | +51103.32% |
| DNTH | Dianthus Therapeutics Inc | $5.45B | +50609.56% |
| APLS | Apellis Pharmaceuticals Inc | $5.25B | +48706.27% |
| TVTX | Travere Therapeutics Inc | $5.24B | +48653.34% |
| CRSP | CRISPR Therapeutics AG | $4.95B | +45941.22% |
| CAI | Caris Life Sciences Inc - Class A | $4.94B | +45790.19% |
| FOLD | Amicus Therapeutics Inc | $4.50B | +41784.21% |
| ACAD | Acadia Pharmaceuticals Inc | $4.43B | +41135.90% |
| CELC | Celcuity Inc | $4.42B | +41040.26% |
| EWTX | Edgewise Therapeutics Inc | $4.39B | +40707.38% |
| VKTX | Viking Therapeutics Inc | $4.38B | +40646.74% |
| AKRO | Akero Therapeutics Inc | $4.38B | +40630.05% |
| TNGX | Tango Therapeutics Inc | $4.36B | +40451.16% |
| ORKA | ARCA biopharma Inc | $4.35B | +40321.98% |
| LEGN | Legend Biotech Corp | $4.26B | +39477.89% |
| DYN | Dyne Therapeutics Inc | $3.96B | +36752.70% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.85B | +35676.92% |
| TLX | Telix Pharmaceuticals Ltd | $3.82B | +35465.97% |
| NAMS | NewAmsterdam Pharma Company NV | $3.73B | +34586.27% |
| RLAY | Relay Therapeutics Inc | $3.69B | +34226.19% |
| DNLI | Denali Therapeutics Inc | $3.65B | +33861.60% |
| ALMS | Alumis Inc | $3.60B | +33400.76% |
| GPCR | Structure Therapeutics Inc | $3.53B | +32691.74% |
| RCUS | Arcus Biosciences Inc | $3.52B | +32599.22% |
| ARQT | Arcutis Biotherapeutics Inc | $3.47B | +32200.83% |
| ELVN | Enliven Therapeutics Inc | $3.24B | +29999.13% |
| IDYA | Ideaya Biosciences Inc | $3.23B | +29914.90% |
| BEAM | Beam Therapeutics Inc | $3.17B | +29363.70% |
| RARE | Ultragenyx Pharmaceutical Inc | $3.12B | +28885.13% |
| VERA | Vera Therapeutics Inc - Class A | $3.04B | +28147.39% |
| IRON | Disc Medicine Inc | $2.90B | +26896.55% |
| MBX | MBX Biosciences Inc | $2.89B | +26739.39% |
| SLNO | Soleno Therapeutics Inc | $2.74B | +25393.31% |
| KOD | Kodiak Sciences Inc | $2.64B | +24417.55% |
| IMNM | Immunome Inc | $2.59B | +24019.97% |
| QURE | uniQure N.V. | $2.58B | +23931.40% |
| CLDX | Celldex Therapeutics Inc | $2.55B | +23614.26% |
| TARS | Tarsus Pharmaceuticals Inc | $2.47B | +22902.60% |
| NRIX | Nurix Therapeutics Inc | $2.47B | +22898.47% |
| MLYS | Mineralys Therapeutics Inc | $2.43B | +22512.73% |
| VCEL | Vericel Corp | $2.38B | +22060.71% |
| AGIO | Agios Pharmaceuticals Inc | $2.37B | +21900.32% |
| MESO | Mesoblast Ltd | $2.36B | +21814.38% |
| ETNB | 89bio Inc | $2.34B | +21686.48% |
| TRVI | Trevi Therapeutics Inc | $2.33B | +21566.31% |
| SLS | SELLAS Life Sciences Group Inc | $2.32B | +21466.11% |
| PHVS | Pharvaris NV | $2.30B | +21251.21% |
| ZLAB | Zai Lab Ltd | $2.27B | +21001.84% |
| BHVN | Biohaven Ltd | $2.24B | +20710.94% |
| DAWN | Day One Biopharmaceuticals Inc | $2.22B | +20517.40% |
| OCUL | Ocular Therapeutix Inc | $2.18B | +20173.30% |
| PVLA | Palvella Therapeutics Inc | $2.18B | +20127.12% |
| AUPH | Aurinia Pharmaceuticals Inc | $2.11B | +19477.75% |
| SNDX | Syndax Pharmaceuticals Inc | $2.08B | +19265.17% |
| IOVA | Iovance Biotherapeutics Inc | $2.08B | +19210.06% |
| ABCL | AbCellera Biologics Inc | $2.05B | +18949.40% |
| NUVB | Nuvation Bio Inc - Class A | $2.04B | +18910.14% |
| HRMY | Harmony Biosciences Holdings Inc | $2.02B | +18679.53% |
| ADMA | Adma Biologics Inc | $2.02B | +18648.81% |
| SION | Sionna Therapeutics Inc | $2.00B | +18501.79% |
| GLUE | Monte Rosa Therapeutics Inc | $1.97B | +18255.50% |
| ATAI | ATAI Life Sciences N.V. | $1.96B | +18120.17% |
| VRDN | Viridian Therapeutics Inc | $1.95B | +18059.11% |
| URGN | UroGen Pharma Ltd | $1.94B | +17926.50% |
| TYRA | Tyra Biosciences Inc | $1.93B | +17805.98% |
| NBTX | Nanobiotix | $1.91B | +17668.76% |
| RAPP | Rapport Therapeutics Inc | $1.91B | +17650.90% |
| GLPG | Galapagos NV | $1.90B | +17551.55% |
| AAPG | Ascentage Pharma Group International | $1.87B | +17276.88% |
| STOK | Stoke Therapeutics Inc | $1.86B | +17210.67% |
| SRPT | Sarepta Therapeutics Inc | $1.86B | +17187.42% |
| BCAX | Bicara Therapeutics Inc | $1.84B | +17036.28% |
| ZBIO | Zenas Biopharma Inc | $1.83B | +16960.41% |
| PGEN | Precigen Inc | $1.82B | +16844.48% |
| ZYME | Zymeworks BC Inc | $1.80B | +16663.01% |
| TSHA | Taysha Gene Therapies Inc | $1.78B | +16435.48% |
| IMCR | Immunocore Holdings plc | $1.76B | +16292.35% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | $1.76B | +16232.18% |
| FTRE | Fortrea Holdings Inc | $1.69B | +15654.78% |
| NKTR | Nektar Therapeutics | $1.69B | +15610.02% |
| MPLT | MapLight Therapeutics Inc | $1.69B | +15593.06% |
| GHRS | GH Research PLC | $1.67B | +15428.54% |
| ANAB | AnaptysBio Inc | $1.62B | +14968.64% |
| INVA | Innoviva Inc | $1.62B | +14923.62% |
| NTLA | Intellia Therapeutics Inc | $1.57B | +14504.98% |
| RAPT | RAPT Therapeutics Inc | $1.56B | +14446.99% |
| VIR | Vir Biotechnology Inc | $1.55B | +14308.07% |
| SEPN | Septerna Inc | $1.53B | +14129.98% |
| AVBP | ArriVent BioPharma Inc | $1.49B | +13782.41% |
| ABSI | Absci Corp | $1.49B | +13782.21% |
| MAZE | Maze Therapeutics Inc | $1.46B | +13492.84% |
| MLTX | MoonLake Immunotherapeutics - Class A | $1.42B | +13128.63% |
| NVAX | Novavax Inc | $1.39B | +12788.86% |
| KALV | KalVista Pharmaceuticals Inc | $1.38B | +12764.04% |
| INBX | Inhibrx Biosciences Inc | $1.33B | +12290.39% |
| ARDX | Ardelyx Inc | $1.31B | +12071.71% |
| IMTX | Immatics N.V | $1.28B | +11756.75% |
| MNKD | Mannkind Corp | $1.26B | +11648.35% |
| ANNX | Annexon Inc | $1.26B | +11637.84% |
| CRVS | Corvus Pharmaceuticals Inc | $1.25B | +11566.51% |
| TRML | Tourmaline Bio Inc | $1.24B | +11390.72% |
| SVRA | Savara Inc | $1.19B | +10971.09% |
| CAPR | Capricor Therapeutics Inc | $1.17B | +10811.88% |
| EYPT | EyePoint Pharmaceuticals Inc | $1.16B | +10647.74% |
| ORIC | ORIC Pharmaceuticals Inc | $1.15B | +10619.98% |
| WVE | Wave Life Sciences Ltd | $1.14B | +10470.05% |
| XNCR | Xencor Inc | $1.11B | +10216.79% |
| DRTS | Alpha Tau Medical Ltd | $1.10B | +10097.04% |
| CGEM | Cullinan Oncology Inc | $1.10B | +10088.46% |
| JBIO | Jade Biosciences Inc | $1.08B | +9930.61% |
| CVAC | CureVac N.V. | $1.05B | +9657.25% |
| OLMA | Olema Pharmaceuticals Inc | $1.03B | +9498.89% |
| MGTX | MeiraGTx Holdings plc | $1.02B | +9412.30% |
| KURA | Kura Oncology Inc | $1.01B | +9251.63% |
| VTYX | Ventyx Biosciences Inc | $998.72M | +9186.84% |
| GRCL | Gracell Biotechnologies Inc | $989.87M | +9104.55% |
| VOR | Vor Biopharma Inc | $979.68M | +9009.78% |
| JANX | Janux Therapeutics Inc | $975.67M | +8972.56% |
| ANRO | Alto Neuroscience Inc | $973.06M | +8948.30% |
| SANA | Sana Biotechnology Inc | $957.85M | +8806.83% |
| GERN | Geron Corp | $950.51M | +8738.60% |
| SLDB | Solid Biosciences Inc | $946.56M | +8701.82% |
| PHAR | Pharming Group N.V. | $939.88M | +8639.74% |
| LXRX | Lexicon Pharmaceuticals Inc | $936.56M | +8608.84% |
| DBVT | DBV Technologies | $930.17M | +8549.39% |
| LBRX | LB Pharmaceuticals Inc | $922.18M | +8475.16% |
| ABUS | Arbutus Biopharma Corp | $898.08M | +8251.06% |
| PHAT | Phathom Pharmaceuticals Inc | $877.84M | +8062.81% |
| TBPH | Theravance Biopharma Inc | $872.15M | +8009.91% |
| DSGN | Design Therapeutics Inc | $844.21M | +7750.10% |
| REPL | Replimune Group Inc | $800.70M | +7345.52% |
| ACRS | Aclaris Therapeutics Inc | $782.06M | +7172.16% |
| OCS | Oculis Holding AG | $772.84M | +7086.44% |
| ZVRA | Zevra Therapeutics Inc | $766.13M | +7024.05% |
| CMRX | Chimerix Inc | $766.03M | +7023.14% |
| RIGL | Rigel Pharmaceuticals | $758.21M | +6950.38% |
| SPRY | ARS Pharmaceuticals Inc | $749.72M | +6871.44% |
| OMER | Omeros Corporation | $746.63M | +6842.70% |
| MNPR | Monopar Therapeutics Inc | $728.12M | +6670.63% |
| DRUG | Bright Minds Biosciences Inc | $728.06M | +6670.07% |
| ATXS | Astria Therapeutics Inc | $709.95M | +6501.67% |
| CADL | Candel Therapeutics Inc | $706.21M | +6466.85% |
| XOMA | XOMA Royalty Corp | $699.64M | +6405.80% |
| BBOT | BridgeBio Oncology Therapeutics Inc Com | $673.55M | +6163.17% |
| CLYM | Eliem Therapeutics Inc | $662.55M | +6060.90% |
| CRMD | CorMedix Inc | $660.09M | +6038.01% |
| IVA | Inventiva | $655.21M | +5992.69% |
| RLMD | Relmada Therapeutics Inc | $651.37M | +5956.92% |
| MDXG | Mimedx Group Inc | $635.94M | +5813.43% |
| RGNX | Regenxbio Inc | $633.34M | +5789.29% |
| PRME | Prime Medicine Inc | $630.35M | +5761.46% |
| NGNE | Neoleukin Therapeutics Inc | $616.04M | +5628.44% |
| TECX | AvroBio Inc | $611.99M | +5590.75% |
| FDMT | 4D Molecular Therapeutics Inc | $610.53M | +5577.20% |
| GYRE | Gyre Therapeutics Inc | $599.17M | +5471.56% |
| IMMX | Immix Biopharma Inc | $558.22M | +5090.73% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | $555.56M | +5066.06% |
| CTNM | Contineum Therapeutics Inc - Class A | $546.27M | +4979.64% |
| ARVN | Arvinas Inc | $534.06M | +4866.10% |
| NVCT | Nuvectis Pharma Inc | $519.64M | +4731.97% |
| STTK | Shattuck Labs Inc | $511.69M | +4658.08% |
| ZURA | Zura Bio Ltd - Class A | $511.41M | +4655.46% |
| VSTM | Verastem Inc | $503.34M | +4580.45% |
| SLN | Silence Therapeutics Plc | $493.60M | +4489.89% |
| OCGN | Ocugen Inc | $483.80M | +4398.71% |
| KYTX | Kyverna Therapeutics Inc | $470.94M | +4279.19% |
| ALLO | Allogene Therapeutics Inc | $465.15M | +4225.33% |
| SVA | Sinovac Biotech Ltd | $464.94M | +4223.36% |
| CABA | Cabaletta Bio Inc | $463.15M | +4206.73% |
| RZLT | Rezolute Inc | $456.43M | +4144.20% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | $451.41M | +4097.57% |
| EVMN | Evommune Inc | $447.71M | +4063.14% |
| PRTA | Prothena Corporation plc | $447.44M | +4060.65% |
| BNTC | Benitec Biopharma Inc | $447.29M | +4059.28% |
| VALN | Valneva SE | $440.98M | +4000.56% |
| CBIO | N/A | $432.05M | +3917.55% |
| STRO | Sutro Biopharma Inc | $430.74M | +3905.32% |
| AURA | Aura Biosciences Inc | $430.49M | +3903.02% |
| PBYI | Puma Biotechnology Inc | $427.89M | +3878.89% |
| ASMB | Assembly Biosciences Inc | $424.80M | +3850.14% |
| OVID | Ovid Therapeutics Inc | $416.49M | +3772.88% |
| ABEO | Abeona Therapeutics Inc | $414.56M | +3754.86% |
| DMAC | DiaMedica Therapeutics Inc | $411.67M | +3728.01% |
| CYBN | Cybin Inc | $408.43M | +3697.92% |
| AVTX | Avalo Therapeutics Inc | $403.76M | +3654.50% |
| AUTL | Autolus Therapeutics plc | $401.88M | +3636.96% |
| RCKT | Rocket Pharmaceuticals Inc | $398.30M | +3603.71% |
| LRMR | Larimar Therapeutics Inc | $395.79M | +3580.40% |
| UPB | Upstream Bio Inc | $395.63M | +3578.90% |
| CCCC | C4 Therapeutics Inc | $395.34M | +3576.16% |
| IPSC | Century Therapeutics Inc | $390.82M | +3534.16% |
| YMAB | Y-Mabs Therapeutics Inc | $390.19M | +3528.27% |
| AVIR | Atea Pharmaceuticals Inc | $388.93M | +3516.59% |
| CMPX | Compass Therapeutics Inc | $385.39M | +3483.64% |
| ENTA | Enanta Pharmaceuticals Inc | $384.48M | +3475.16% |
| RVNC | Revance Therapeutics Inc | $380.38M | +3437.04% |
| PRTC | PureTech Health plc American Depositary Shares | $376.98M | +3405.49% |
| ALT | Altimmune Inc | $373.67M | +3374.72% |
| TENX | Tenax Therapeutics Inc | $372.39M | +3362.73% |
| PRLD | Prelude Therapeutics Inc | $368.04M | +3322.31% |
| XFOR | X4 Pharmaceuticals Inc | $367.85M | +3320.52% |
| FENC | Fennec Pharmaceuticals Inc | $366.13M | +3304.60% |
| VNDA | Vanda Pharmaceuticals Inc | $351.79M | +3171.22% |
| LXEO | Lexeo Therapeutics Inc | $351.17M | +3165.46% |
| EDIT | Editas Medicine Inc | $349.39M | +3148.85% |
| FATE | Fate Therapeutics Inc | $347.65M | +3132.76% |
| FBRX | Forte Biosciences Inc | $340.15M | +3063.00% |
| ZNTL | Zentalis Pharmaceuticals Inc | $340.13M | +3062.76% |
| PALI | Palisade Bio Inc | $339.87M | +3060.34% |
| IMAB | I-Mab | $339.64M | +3058.20% |
| EPRX | Eupraxia Pharmaceuticals Inc | $338.64M | +3048.97% |
| IMRX | Immuneering Corp Class A | $333.64M | +3002.44% |
| LYEL | Lyell Immunopharma Inc | $332.66M | +2993.36% |
| FHTX | Foghorn Therapeutics Inc | $319.97M | +2875.35% |
| INDP | Indaptus Therapeutics Inc | $319.34M | +2869.50% |
| ANL | Adlai Nortye Ltd | $317.46M | +2851.94% |
| GALT | Galectin Therapeutics Inc | $313.48M | +2814.97% |
| LCTX | Lineage Cell Therapeutics Inc | $305.39M | +2739.76% |
| VTVT | vTv Therapeutics Inc - Class A | $305.06M | +2736.68% |
| ELDN | Eledon Pharmaceuticals Inc | $304.92M | +2735.42% |
| SCPH | scPharmaceuticals Inc | $304.59M | +2732.32% |
| ARTV | Artiva Biotherapeutics Inc | $302.86M | +2716.24% |
| OABI | OmniAb Inc | $301.15M | +2700.33% |
| BCYC | Bicycle Therapeutics Plc | $294.16M | +2635.36% |
| NMRA | Neumora Therapeutics Inc | $293.19M | +2626.32% |
| GLSI | Greenwich LifeSciences Inc | $286.57M | +2564.78% |
| TTRX | Turn Therapeutics Inc | $285.37M | +2553.58% |
| CLLS | Cellectis | $282.48M | +2526.73% |
| TRDA | Entrada Therapeutics Inc | $276.01M | +2466.60% |
| NAGE | Niagen Bioscience Inc | $275.72M | +2463.82% |
| MGNX | Macrogenics Inc | $274.58M | +2453.25% |
| SABS | SAB Biotherapeutics Inc | $274.20M | +2449.68% |
| ALXO | Alx Oncology Holdings Inc | $273.12M | +2439.66% |
| IKT | Inhibikase Therapeutics Inc | $271.99M | +2429.15% |
| SRZN | Surrozen Inc | $250.37M | +2228.11% |
| IRD | Ocuphire Pharma Inc | $248.48M | +2210.56% |
| RNAC | Cartesian Therapeutics Inc | $247.77M | +2203.94% |
| THRD | Third Harmonic Bio Inc | $241.86M | +2149.04% |
| FULC | Fulcrum Therapeutics Inc | $237.12M | +2104.97% |
| GNFT | GENFIT S.A. American Depositary Shares | $233.01M | +2066.72% |
| ACIU | AC Immune SA | $232.87M | +2065.40% |
| AVXL | Anavex Life Sciences Corporation | $231.68M | +2054.33% |
| IVVD | Invivyd Inc | $231.05M | +2048.49% |
| QTTB | Q32 Bio Inc | $229.68M | +2035.77% |
| SLRN | Acelyrin Inc | $228.54M | +2025.18% |
| DTIL | Precision Biosciences Inc | $227.35M | +2014.07% |
| TARA | Protara Therapeutics Inc | $226.83M | +2009.23% |
| CGEN | Compugen Ltd | $223.15M | +1974.98% |
| CHRS | Coherus Biosciences Inc | $222.07M | +1965.01% |
| NAUT | Nautilus Biotechnology Inc | $221.10M | +1955.98% |
| CAMP | CAMP4 Therapeutics Corp | $218.61M | +1932.78% |
| KROS | Keros Therapeutics Inc | $217.65M | +1923.91% |
| ADAG | Adagene Inc | $217.38M | +1921.38% |
| SLGL | Sol-Gel Technologies Ltd | $215.10M | +1900.21% |
| KPTI | Karyopharm Therapeutics Inc | $214.84M | +1897.79% |
| OBIO | Orchestra BioMed Holdings Inc | $214.00M | +1889.96% |
| RNA | Atrium Therapeutics Inc | $210.40M | +1856.46% |
| IMUX | Immunic Inc | $205.68M | +1812.61% |
| TLSA | Tiziana Life Sciences Ltd | $201.81M | +1776.55% |
| CDXS | Codexis Inc | $200.88M | +1767.90% |
| NKTX | Nkarta Inc | $197.53M | +1736.75% |
| AGEN | Agenus Inc | $192.99M | +1694.61% |
| VYGR | Voyager Therapeutics Inc | $192.99M | +1694.60% |
| NERV | Minerva Neurosciences Inc | $189.40M | +1661.16% |
| KRRO | Korro Bio Inc | $187.93M | +1647.48% |
| PRQR | ProQR Therapeutics N.V | $186.49M | +1634.14% |
| PLX | Protalix BioTherapeutics Inc | $186.05M | +1630.02% |
| TNYA | Tenaya Therapeutics Inc | $182.97M | +1601.43% |
| MDWD | MediWound Ltd | $182.55M | +1597.53% |
| IFRX | InflaRx N.V. | $182.18M | +1594.03% |
| WHWK | Whitehawk Therapeutics Inc | $181.71M | +1589.65% |
| ARCT | Arcturus Therapeutics Holdings Inc | $181.62M | +1588.87% |
| SGMT | Sagimet Biosciences Inc - Class A | $180.81M | +1581.32% |
| ACOG | Alpha Cognition Inc | $180.73M | +1580.52% |
| MENS | Jyong Biotech Ltd | $174.10M | +1518.95% |
| ACHV | Achieve Life Sciences Inc | $173.54M | +1513.73% |
| PEPG | PepGen Inc | $168.86M | +1470.17% |
| ANTX | AN2 Therapeutics Inc | $168.05M | +1462.68% |
| CRBU | Caribou Biosciences Inc | $167.73M | +1459.64% |
| THTX | Theratechnologies Inc | $167.34M | +1456.02% |
| ALEC | Alector Inc | $166.54M | +1448.60% |
| ORMP | Oramed Pharmaceuticals Inc | $166.16M | +1445.08% |
| EQ | Equillium Inc | $165.65M | +1440.37% |
| TNXP | Tonix Pharmaceuticals Holding Corp | $164.92M | +1433.60% |
| IPHA | Innate Pharma | $164.54M | +1430.03% |
| OTLK | Outlook Therapeutics Inc | $163.20M | +1417.54% |
| YDES | YD Bio Ltd | $160.69M | +1394.23% |
| ABOS | Acumen Pharmaceuticals Inc | $160.35M | +1391.01% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | $159.83M | +1386.20% |
| LENZ | LENZ Therapeutics Inc | $156.46M | +1354.87% |
| PYXS | Pyxis Oncology Inc | $152.68M | +1319.74% |
| CNTB | Connect Biopharma Holdings Ltd | $152.39M | +1317.03% |
| HUMA | Humacyte Inc | $151.33M | +1307.17% |
| MIST | Milestone Pharmaceuticals Inc | $149.60M | +1291.09% |
| NBP | NovaBridge Biosciences. | $149.30M | +1288.29% |
| NRXP | NRX Pharmaceuticals Inc | $149.28M | +1288.14% |
| AKTX | Akari Therapeutics Plc | $148.12M | +1277.38% |
| MOLN | Molecular Partners AG | $146.63M | +1263.52% |
| ARMP | Armata Pharmaceuticals Inc | $146.49M | +1262.14% |
| AARD | Aardvark Therapeutics Inc | $145.52M | +1253.11% |
| MRSN | Mersana Therapeutics Inc | $145.36M | +1251.64% |
| HURA | TuHURA Biosciences Inc | $144.96M | +1247.94% |
| GUTS | Fractyl Health Inc | $144.37M | +1242.47% |
| PROK | ProKidney Corp - Class A | $137.85M | +1181.84% |
| TCRX | Tscan Therapeutics Inc | $137.63M | +1179.75% |
| CBUS | Cibus Global Ltd. Class A | $135.62M | +1161.11% |
| THAR | Tharimmune Inc | $135.41M | +1159.13% |
| SEER | Seer Inc - Class A | $132.16M | +1128.95% |
| GNLX | Genelux Corp | $130.49M | +1113.36% |
| VXRT | Vaxart Inc | $127.95M | +1089.77% |
| ENGN | enGene Holdings Inc | $127.28M | +1083.55% |
| UNCY | Unicycive Therapeutics Inc | $126.69M | +1078.10% |
| PMN | ProMIS Neurosciences Inc | $125.59M | +1067.86% |
| FBIO | Fortress Biotech Inc | $123.12M | +1044.89% |
| RANI | Rani Therapeutics Holdings Inc Class A | $121.86M | +1033.12% |
| VANI | Vivani Medical Inc | $119.35M | +1009.84% |
| ANIX | Anixa Biosciences Inc | $118.73M | +1004.04% |
| ALDX | Aldeyra Therapeutics Inc | $115.82M | +976.95% |
| SAVA | Cassava Sciences Inc. | $114.97M | +969.11% |
| RPTX | Repare Therapeutics Inc | $113.91M | +959.24% |
| COYA | Coya Therapeutics Inc | $113.53M | +955.72% |
| KLRS | Kalaris Therapeutics Inc | $110.82M | +930.52% |
| ONCY | Oncolytics Biotech Inc | $104.98M | +876.18% |
| HLVX | HilleVax Inc | $104.74M | +873.94% |
| BDTX | Black Diamond Therapeutics Inc | $103.72M | +864.43% |
| ADVM | Adverum Biotechnologies Inc | $102.40M | +852.22% |
| SPRO | Spero Therapeutics Inc | $98.42M | +815.14% |
| KZIA | Kazia Therapeutics Ltd | $97.74M | +808.87% |
| VRCA | Verrica Pharmaceuticals Inc | $97.23M | +804.14% |
| ICCC | Immucell Corp | $97.07M | +802.65% |
| PYPD | Polypid Ltd | $94.84M | +781.92% |
| BMEA | Biomea Fusion Inc | $93.27M | +767.26% |
| CUE | Cue Biopharma Inc | $92.75M | +762.42% |
| ENLV | Enlivex Ltd | $92.47M | +759.83% |
| PTHS | Channel Therapeutics Corporation | $91.66M | +752.34% |
| MAIA | MAIA Biotechnology Inc | $89.19M | +729.33% |
| NTHI | NeOnc Technologies Holdings Inc | $87.88M | +717.19% |
| ADAP | Adaptimmune Therapeutics plc American Depositary Shares | $86.99M | +708.90% |
| CRDF | Cardiff Oncology Inc | $85.46M | +694.70% |
| RLYB | Rallybio Corp | $85.33M | +693.48% |
| CGTX | Cognition Therapeutics Inc | $84.81M | +688.59% |
| LPTX | Leap Therapeutics Inc | $84.76M | +688.15% |
| ATHE | Alterity Therapeutics Ltd | $84.66M | +687.24% |
| ACET | Adicet Bio Inc | $83.31M | +674.66% |
| HRTX | Heron Therapeutics Inc | $83.25M | +674.17% |
| ENTX | Entera Bio Ltd | $82.99M | +671.68% |
| INO | Inovio Pharmaceuticals Inc | $81.63M | +659.10% |
| CSBR | Champions Oncology Inc | $80.27M | +646.37% |
| NRXS | Neuraxis Inc | $79.92M | +643.17% |
| FBIOP | Fortress Biotech Inc | $77.72M | +622.70% |
| ATHA | Athira Pharma Inc | $77.21M | +618.00% |
| PMVP | PMV Pharmaceuticals Inc | $74.66M | +594.29% |
| GLTO | Galecto Inc | $74.66M | +594.20% |
| ACRV | Acrivon Therapeutics Inc | $74.39M | +591.74% |
| ATRA | Atara Biotherapeutics Inc | $72.78M | +576.74% |
| MNMD | Mind Medicine (MindMed) Inc. Common Shares | $71.93M | +568.82% |
| GANX | Gain Therapeutics Inc | $71.38M | +563.75% |
| XBIT | XBiotech Inc | $69.82M | +549.21% |
| PLRX | Pliant Therapeutics Inc | $69.34M | +544.82% |
| HYFT | MindWalk Holdings Corp | $69.31M | +544.48% |
| MNOV | Medicinova Inc | $68.91M | +540.78% |
| SPRB | Spruce Biosciences Inc | $67.96M | +531.90% |
| IMA | Ikena Oncology Inc | $67.49M | +527.59% |
| ELTX | Elicio Therapeutics Inc | $65.05M | +504.92% |
| IMMP | Immutep Ltd | $64.23M | +497.26% |
| KLTO | Klotho Neurosciences Inc Com | $63.55M | +490.97% |
| ACHL | Achilles Therapeutics Plc | $63.22M | +487.87% |
| EDSA | Edesa Biotech Inc | $61.04M | +467.64% |
| OSTX | OS Therapies Inc | $60.88M | +466.12% |
| OKUR | Reneo Pharmaceuticals Inc - Class A | $59.20M | +450.48% |
| IBIO | iBio Inc | $58.38M | +442.85% |
| CNTX | Context Therapeutics Inc | $57.91M | +438.51% |
| OKYO | OKYO Pharma Ltd - New | $56.13M | +421.96% |
| BOLD | Boundless Bio Inc | $55.35M | +414.64% |
| INMB | INmune Bio Inc | $55.03M | +411.73% |
| CING | Cingulate Inc | $54.66M | +408.26% |
| KZR | Kezar Life Sciences Inc | $53.76M | +399.89% |
| INKT | MiNK Therapeutics Inc | $53.21M | +394.77% |
| XLO | Xilio Therapeutics Inc | $52.74M | +390.39% |
| MREO | Mereo Biopharma Group Plc | $52.58M | +388.95% |
| ATYR | Atyr Pharma Inc | $52.39M | +387.15% |
| MCRB | Seres Therapeutics Inc | $52.28M | +386.12% |
| BYSI | BeyondSpring Inc | $52.22M | +385.60% |
| EXOZ | Invizyne Technologies Inc | $51.89M | +382.53% |
| RNTX | Rein Therapeutics Inc | $51.79M | +381.62% |
| TIL | Instil Bio Inc | $51.68M | +380.55% |
| ANVS | Annovis Bio Inc | $51.65M | +380.30% |
| GOSS | Gossamer Bio Inc | $51.14M | +375.54% |
| IBO | Impact BioMedical Inc | $50.13M | +366.11% |
| MGX | Metagenomi Inc | $48.56M | +351.59% |
| DWTX | Virios Therapeutics Inc | $48.10M | +347.25% |
| LVTX | LAVA Therapeutics NV | $45.77M | +325.62% |
| TELO | Telomir Pharmaceuticals Inc | $45.73M | +325.20% |
| DYAI | Dyadic International Inc DE | $44.46M | +313.38% |
| PDSB | PDS Biotechnology Corporation | $41.64M | +287.19% |
| APLM | Apollomics Inc - Class A | $41.33M | +284.33% |
| ACTU | Actuate Therapeutics Inc | $40.78M | +279.24% |
| FGEN | FibroGen Inc | $39.31M | +265.50% |
| GRCE | Acasti Pharma Inc | $38.94M | +262.08% |
| VERU | Veru Inc | $38.84M | +261.18% |
| RNXT | RenovoRx Inc | $38.73M | +260.12% |
| NNVC | NanoViricides Inc | $37.23M | +246.22% |
| NTRB | Nutriband Inc | $37.08M | +244.76% |
| RADX | Radiopharm Theranostics Ltd | $36.10M | +235.73% |
| GBIO | Generation Bio Company | $35.97M | +234.46% |
| GNTA | Genenta Science SpA | $35.85M | +233.37% |
| ALGS | Aligos Therapeutics Inc | $35.71M | +232.02% |
| MURA | Mural Oncology plc | $35.34M | +228.64% |
| LTRN | Lantern Pharma Inc | $34.89M | +224.43% |
| LITS | Lite Strategy Inc | $34.77M | +223.34% |
| HYPD | Eyenovia Inc | $34.51M | +220.94% |
| LSTA | Lisata Therapeutics Inc | $34.15M | +217.57% |
| ABVC | ABVC BioPharma Inc | $32.98M | +206.70% |
| ESLA | Estrella Immunopharma Inc | $32.50M | +202.25% |
| SNTI | Senti Biosciences Inc | $32.39M | +201.19% |
| DARE | Dare Bioscience Inc | $30.14M | +180.25% |
| SER | AgeX Therapeutics Inc | $29.05M | +170.16% |
| SGMO | Sangamo Therapeutics Inc | $28.83M | +168.10% |
| BCTX | BriaCell Therapeutics Corp - New | $28.57M | +165.64% |
| ATNM | Actinium Pharmaceuticals Inc | $28.56M | +165.58% |
| CRVO | CervoMed Inc | $28.42M | +164.31% |
| PSTV | Plus Therapeutics Inc | $28.00M | +160.34% |
| TVRD | Cara Therapeutics Inc | $27.49M | +155.60% |
| BRNS | Barinthus Biotherapeutics Plc. | $26.44M | +145.84% |
| IGC | IGC Pharma Inc | $26.36M | +145.10% |
| EVAX | Evaxion Biotech A/S | $25.44M | +136.54% |
| VYNE | VYNE Therapeutics Inc | $25.25M | +134.84% |
| GRDX | Entero Therapeutics Inc | $24.74M | +130.04% |
| NXTC | Nextcure Inc | $23.92M | +122.41% |
| MRKR | Marker Therapeutics Inc | $23.55M | +118.96% |
| NRSN | NeuroSense Therapeutics Ltd | $23.41M | +117.64% |
| CELU | Celularity Inc - Class A | $22.49M | +109.16% |
| COEP | Coeptis Therapeutics Holdings Inc. Common Stock | $21.96M | +104.16% |
| OPT | Opthea Ltd | $21.53M | +100.20% |
| SKYE | Skye Bioscience Inc | $21.29M | +97.97% |
| PLRZ | Polyrizon Ltd | $21.02M | +95.46% |
| ATOS | Atossa Therapeutics Inc | $21.01M | +95.38% |
| PHXM | PHAXIAM Therapeutics SA ADR | $20.38M | +89.47% |
| TVGN | Tevogen Bio Holdings Inc | $19.93M | +85.29% |
| SNSE | Sensei Biotherapeutics Inc | $19.48M | +81.09% |
| JSPR | Jasper Therapeutics Inc | $19.37M | +80.15% |
| KALA | Kala Bio Inc | $19.15M | +78.05% |
| NEUP | Neuphoria Therapeutics Inc | $18.93M | +76.01% |
| NCEL | NLS Pharmaceutics Ltd | $18.85M | +75.32% |
| ALLR | Allarity Therapeutics Inc | $18.67M | +73.57% |
| ICU | SeaStar Medical Holding Corp | $18.45M | +71.57% |
| PLUR | Pluri Inc | $18.25M | +69.74% |
| LPCN | Lipocine Inc | $17.64M | +64.04% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | $17.55M | +63.23% |
| HOWL | Werewolf Therapeutics Inc | $16.50M | +53.42% |
| HIND | ReShape Lifesciences Inc | $15.93M | +48.15% |
| PTN | Palatin Technologies Inc | $15.81M | +47.00% |
| PASG | Passage Bio Inc | $15.75M | +46.46% |
| LGVN | Longeveron Inc - Class A | $15.75M | +46.43% |
| CYCN | Cyclerion Therapeutics Inc | $15.74M | +46.32% |
| TPST | Tempest Therapeutics Inc | $15.35M | +42.72% |
| CLRB | Cellectar Biosciences Inc | $14.97M | +39.18% |
| APLT | Applied Therapeutics Inc | $14.86M | +38.21% |
| HOTH | Hoth Therapeutics Inc | $14.64M | +36.17% |
| LEXX | Lexaria Bioscience Corp | $14.58M | +35.55% |
| IOBT | IO Biotech Inc | $14.50M | +34.82% |
| HOOK | Hookipa Pharma Inc | $14.43M | +34.15% |
| INAB | IN8bio Inc | $14.18M | +31.85% |
| OSRH | Bellevue Life Sciences Acquisition Corp | $14.00M | +30.18% |
| ANEB | Anebulo Pharmaceuticals, Inc. Common Stock | $13.82M | +28.52% |
| BIVI | BioVie Inc - Class A | $13.35M | +24.13% |
| BLRX | Bioline Rx Ltd | $13.35M | +24.10% |
| LNAI | Lunai Bioworks Inc | $13.33M | +23.91% |
| COCP | Cocrystal Pharma Inc | $13.24M | +23.07% |
| QNCX | Quince Therapeutics Inc | $13.03M | +21.20% |
| LSB | LakeShore Biopharma Co Ltd | $13.02M | +21.08% |
| GTBP | GT Biopharma Inc | $12.33M | +14.63% |
| MBRX | Moleculin Biotech Inc | $12.33M | +14.63% |
| CALC | CalciMedica Inc | $12.31M | +14.43% |
| INTS | Intensity Therapeutics Inc | $12.30M | +14.34% |
| AIM | AIM ImmunoTech Inc. | $12.01M | +11.68% |
| KTTA | Pasithea Therapeutics Corp | $11.92M | +10.85% |
| QNRX | Quoin Pharmaceuticals Ltd | $11.92M | +10.83% |
| GDTC | CytoMed Therapeutics Ltd | $11.32M | +5.27% |
| TOVX | Theriva Biologics Inc | $11.15M | +3.66% |
| CMMB | Chemomab Therapeutics Ltd | $10.93M | +1.66% |
| BCLI | Brainstorm Cell Therapeutics Inc | $10.73M | -0.19% |
| KLTOW | Klotho Neurosciences Inc Wt Exp | $10.43M | -3.05% |
| PHIO | Phio Pharmaceuticals Corp | $10.34M | -3.85% |
| XCUR | Exicure Inc | $10.33M | -3.98% |
| CVM | Cel-Sci Corp | $10.15M | -5.66% |
| MLEC | Moolec Science SA | $10.06M | -6.48% |
| KPRX | Kiora Pharmaceuticals Inc | $9.90M | -7.91% |
| BCDA | BioCardia Inc | $9.59M | -10.86% |
| MTVA | MetaVia Inc | $9.55M | -11.16% |
| VTGN | VistaGen Therapeutics Inc | $9.48M | -11.88% |
| CRIS | Curis Inc | $9.45M | -12.08% |
| TRAW | Traws Pharma Inc | $9.16M | -14.81% |
| ASBP | Aspire Biopharma Holdings Inc | $9.03M | -16.04% |
| EPIX | Essa Pharma Inc | $8.93M | -16.95% |
| SONN | Sonnet BioTherapeutics Holdings Inc | $8.92M | -17.08% |
| IMNN | Imunon Inc | $8.71M | -19.04% |
| BRTX | BioRestorative Therapies Inc | $8.66M | -19.45% |
| APRE | Aprea Therapeutics Inc | $8.48M | -21.16% |
| ADXN | Addex Therapeutics Ltd | $8.21M | -23.70% |
| SYBX | Synlogic Inc | $8.20M | -23.72% |
| IMRN | Immuron Ltd | $8.15M | -24.19% |
| BOLT | Bolt Biotherapeutics Inc | $8.09M | -24.77% |
| ITRM | Iterum Therapeutics Plc | $8.06M | -25.04% |
| RNAZ | TransCode Therapeutics Inc | $7.97M | -25.86% |
| ERNA | Ernexa Therapeutics Inc | $7.85M | -27.03% |
| PMCB | PharmaCyte Biotech Inc | $7.57M | -29.58% |
| RVPH | Reviva Pharmaceuticals Holdings Inc | $7.49M | -30.40% |
| XTLB | X.T.L. Biopharmaceuticals Ltd | $7.34M | -31.79% |
| AEON | AEON Biopharma Inc - Class A | $7.31M | -32.03% |
| BCAB | BioAtla Inc | $7.07M | -34.26% |
| CANF | Can-Fite Biopharma Ltd | $6.87M | -36.07% |
| KAPA | Kairos Pharma Ltd | $6.75M | -37.24% |
| XBIO | Xenetic Biosciences Inc | $6.65M | -38.15% |
| JUNS | Jupiter Neurosciences Inc | $6.48M | -39.78% |
| PCSA | Processa Pharmaceuticals Inc | $6.40M | -40.49% |
| GOVX | Geovax Labs Inc | $6.29M | -41.55% |
| CURX | Curanex Pharmaceuticals Inc | $6.11M | -43.21% |
| PPBT | Purple Biotech Ltd | $6.05M | -43.75% |
| HCWB | HCW Biologics Inc | $6.02M | -44.00% |
| APM | Aptorum Group Limited Class A Ordinary Shares | $6.01M | -44.09% |
| ACXP | Acurx Pharmaceuticals Inc | $5.93M | -44.85% |
| CVKD | Cadrenal Therapeutics Inc | $5.89M | -45.22% |
| PULM | Pulmatrix Inc | $5.73M | -46.68% |
| EVGN | Evogene Ltd | $5.64M | -47.52% |
| APVO | Aptevo Therapeutics Inc | $5.50M | -48.85% |
| CDIO | Cardio Diagnostics Holdings Inc | $5.30M | -50.74% |
| SILO | SILO Pharma Inc | $5.29M | -50.82% |
| DRMA | Dermata Therapeutics Inc | $5.23M | -51.38% |
| LIMN | Liminatus Pharma Inc | $5.14M | -52.22% |
| TCRT | Alaunos Therapeutics Inc | $5.07M | -52.89% |
| BGMS | Bio Green Med Solution Inc | $5.00M | -53.53% |
| NCNA | NuCana plc | $4.99M | -53.59% |
| TTNP | Titan Pharmaceuticals Inc (de) | $4.91M | -54.35% |
| CLGN | CollPlant Biotechnologies Ltd New | $4.80M | -55.40% |
| ALZN | Alzamend Neuro Inc | $4.68M | -56.48% |
| GNPX | Genprex Inc | $4.44M | -58.71% |
| CASI | CASI Pharmaceuticals Inc | $4.27M | -60.34% |
| ENTO | Entero Therapeutics, Inc. Common Stock | $4.26M | -60.35% |
| REVB | Revelation Biosciences Inc | $4.26M | -60.39% |
| MBIO | Mustang Bio Inc | $4.25M | -60.45% |
| ADIL | Adial Pharmaceuticals Inc | $4.24M | -60.57% |
| ENVB | Enveric Biosciences Inc | $4.15M | -61.39% |
| CNSP | Cns Pharmaceuticals Inc | $4.14M | -61.52% |
| SXTP | 60 Degrees Pharmaceuticals Inc | $4.09M | -62.00% |
| SNGX | Soligenix Inc | $3.91M | -63.62% |
| PBM | Psyence Biomedical Ltd | $3.76M | -65.01% |
| CELZ | Creative Medical Technology Holdings Inc | $3.70M | -65.63% |
| GLMD | Galmed Pharmaceuticals Ltd | $3.38M | -68.57% |
| XRTX | XORTX Therapeutics Inc | $3.34M | -68.92% |
| FBLG | FibroBiologics Inc | $3.18M | -70.43% |
| SLXN | Silexion Therapeutics Corp | $3.11M | -71.08% |
| SPRC | SciSparc Ltd | $3.05M | -71.68% |
| BDRX | Biodexa Pharmaceuticals Plc | $2.98M | -72.27% |
| AFMD | Affimed N.V. | $2.98M | -72.33% |
| ENSC | Ensysce Biosciences Inc | $2.88M | -73.26% |
| ARTL | Artelo Biosciences Inc | $2.75M | -74.46% |
| GRI | GRI Bio Inc | $2.57M | -76.12% |
| ONCO | Onconetix Inc | $2.54M | -76.39% |
| PPCB | Propanc Biopharma Inc | $2.50M | -76.74% |
| VIVS | VivoSim Labs Inc | $2.47M | -77.04% |
| OGEN | Oragenics Inc | $2.45M | -77.21% |
| NBY | Stablecoin Development Corp | $2.40M | -77.64% |
| NTBL | Notable Labs Inc Ord | $2.39M | -77.73% |
| BBLG | Bone Biologics Corp | $2.23M | -79.30% |
| AZTR | Azitra Inc | $2.22M | -79.33% |
| MTNB | Matinas Biopharma Holdings Inc | $2.18M | -79.70% |
| CLSD | Clearside Biomedical, Inc. Common Stock | $2.15M | -80.05% |
| CMND | Clearmind Medicine Inc | $2.12M | -80.33% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | $2.09M | -80.58% |
| CLDI | Calidi Biotherapeutics Inc | $1.99M | -81.46% |
| ONCT | Oncternal Therapeutics Inc | $1.56M | -85.51% |
| VRAX | Virax Biolabs Group Ltd - Class A | $1.52M | -85.87% |
| ABP | Abpro Holdings, Inc Common Stock | $1.43M | -86.73% |
| JAGX | Jaguar Health Inc | $1.34M | -87.51% |
| ZVSA | ZyVersa Therapeutics Inc | $1.03M | -90.42% |
| LYRA | Lyra Therapeutics Inc | $927198.36 | -91.38% |
| SCNI | Scinai Immunotherapeutics Ltd | $912143.15 | -91.52% |
| TNFA | TNF Pharmaceuticals Inc | $551031.39 | -94.88% |
| PTIX | Protagenic Therapeutics Inc | $503648.74 | -95.32% |
| SLRX | Decoy Therapeutics Inc | $446853.12 | -95.84% |
| ELAB | PMGC Holdings Inc | $221376.00 | -97.94% |
| CDT | CDT Equity Inc | $110551.31 | -98.97% |
| ADTX | Aditxt Inc | $98471.97 | -99.08% |